These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15697324)

  • 21. Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study.
    Shin JY; Choi NK; Jung SY; Lee J; Kwon JS; Park BJ
    J Psychopharmacol; 2013 Jul; 27(7):638-44. PubMed ID: 23535349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van der Mast RC
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):726-7; author reply 727. PubMed ID: 15819141
    [No Abstract]   [Full Text] [Related]  

  • 23. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    Hafkamp GJ
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):726; author reply 727. PubMed ID: 15819140
    [No Abstract]   [Full Text] [Related]  

  • 24. Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly.
    Percudani M; Barbui C; Fortino I; Tansella M; Petrovich L
    J Clin Psychopharmacol; 2005 Oct; 25(5):468-70. PubMed ID: 16160623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?
    Herrmann N; Lanctôt KL
    Drug Saf; 2006; 29(10):833-43. PubMed ID: 16970508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSM warning on atypical psychotics and stroke may be detrimental for dementia.
    Mowat D; Fowlie D; MacEwan T
    BMJ; 2004 May; 328(7450):1262. PubMed ID: 15155521
    [No Abstract]   [Full Text] [Related]  

  • 29. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.
    Gareri P; De Fazio P; Manfredi VG; De Sarro G
    J Clin Psychopharmacol; 2014 Feb; 34(1):109-23. PubMed ID: 24158020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
    Marras C; Herrmann N; Anderson GM; Fischer HD; Wang X; Rochon PA
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):381-9. PubMed ID: 23217531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of atypical antipsychotics in elderly patients with dementia.
    Tariot PN; Profenno LA; Ismail MS
    J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline characteristics and treatment-emergent risk factors associated with cerebrovascular event and death with risperidone in dementia patients.
    Howard R; Costafreda SG; Karcher K; Coppola D; Berlin JA; Hough D
    Br J Psychiatry; 2016 Nov; 209(5):378-384. PubMed ID: 27388570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effectiveness of atypical antipsychotics in dementia.
    Tariot PN
    J Clin Psychiatry; 2004; 65 Suppl 11():3-4. PubMed ID: 15264964
    [No Abstract]   [Full Text] [Related]  

  • 34. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
    Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC
    JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.
    Pratt N; Roughead EE; Salter A; Ryan P
    BMC Med Res Methodol; 2012 Jun; 12():72. PubMed ID: 22682666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.
    Shah A; Suh GH
    Int Psychogeriatr; 2005 Mar; 17(1):12-22; discussion 22-9. PubMed ID: 15945589
    [No Abstract]   [Full Text] [Related]  

  • 37. [Psychopharmacological treatment of behavioral and psychological symptoms in dementia].
    Lolk A; Gulmann NC
    Ugeskr Laeger; 2006 Oct; 168(40):3429-32. PubMed ID: 17032610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: a hospital-based, retrospective, cohort study.
    Chan MC; Chong CS; Wu AY; Wong KC; Dunn EL; Tang OW; Chan WF
    Int J Geriatr Psychiatry; 2010 Apr; 25(4):362-70. PubMed ID: 19650162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.
    Ritchie CW; Chiu E; Harrigan S; Hall K; Hassett A; Macfarlane S; Mastwyk M; O'Connor DW; Opie J; Ames D
    Int J Geriatr Psychiatry; 2003 May; 18(5):432-40. PubMed ID: 12766921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia.
    Bhana N; Spencer CM
    Drugs Aging; 2000 Jun; 16(6):451-71. PubMed ID: 10939309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.